Catheter News and Research RSS Feed - Catheter News and Research

In medicine, a catheter is a tube that can be inserted into a body cavity, duct, or vessel. Catheters . In most uses, a catheter is a thin, flexible tube ("soft" catheter), though in some uses, it is a larger, solid ("hard") catheter. A catheter left inside the body, either temporarily or permanently, may be referred to as an indwelling catheter. A permanently inserted catheter may be referred to as a permcath.
Loyola University Medical Center physicians deploy aortic valve through patient's abdomen

Loyola University Medical Center physicians deploy aortic valve through patient's abdomen

In a first-of-its-kind procedure in the United States, Loyola University Medical Center physicians have deployed an aortic valve by going through a patient's abdomen. [More]

EKOS presents results of DUET trial at 35th Annual Charing Cross International Symposium

EKOS Corporation, a privately held medical device company located in Bothell, Washington, announced the results of DUET, the world's first and only multi-center randomized trial that compares ultrasound-accelerated, catheter-directed thrombolysis to standard side-hole, catheter-directed thrombolysis for the treatment of acute peripheral arterial thrombotic occlusions. [More]

New generation of innovative medical devices to be created by Curie-Cancer and Vygon partnership

Curie-Cancer, the body responsible for developing Institut Curie’s industry partnership activities and Vygon, a French family-run business that develops, produces and markets medical devices, including catheters and implantable ports for administering chemotherapy treatments, today announce their partnership to develop a new generation of innovative medical devices; mainly for use in chemotherapy. The partnership aims to introduce them to European, the US and Asian markets. [More]
Frozen balls of ice can safely kill cancerous tumors in lungs

Frozen balls of ice can safely kill cancerous tumors in lungs

Frozen balls of ice can safely kill cancerous tumors that have spread to the lungs, according to the first prospective multicenter trial of cryoablation. The results are being presented at the Society of Interventional Radiology's 38th Annual Scientific Meeting in New Orleans. [More]
Drug-eluting stents can keep clogged leg arteries open and prevent leg amputation

Drug-eluting stents can keep clogged leg arteries open and prevent leg amputation

Drug-eluting stents can keep clogged leg arteries open, preventing amputation of the leg, suggests research being presented at the Society of Interventional Radiology's 38th Annual Scientific Meeting in New Orleans. [More]

Computational simulations can help understand, treat cardiac rhythm disorders

Computational models of the human heart can be very useful in studying not just the basic mechanisms of heart function, but also to analyze the heart in a diseased state, and come up with methods for diagnosis and therapy. [More]
FDA approves CryoLife's next generation HeRO device

FDA approves CryoLife's next generation HeRO device

CryoLife, Inc., a leading tissue processing and medical device company focused on cardiac and vascular surgery, announced today that it has received U.S. Food and Drug Administration 510(k) clearance for a next generation HeRO (Hemodialysis Reliable Outflow) device. [More]

Argon Medical Devices releases OptionELITE Retrievable Vena Cava Filter

Continuing our commitment to provide best-in-class medical devices for the prevention of recurrent pulmonary embolism, Argon Medical Devices, Inc. takes another step forward with the launch of the Option™ELITE Retrievable Vena Cava Filter. [More]
AngioDynamics supports SIRF's Discovery Campaign to expand minimally invasive medicine

AngioDynamics supports SIRF's Discovery Campaign to expand minimally invasive medicine

The Society of Interventional Radiology Foundation's Discovery campaign will benefit from a $500,000 pledge by new "Futurist" level supporter, medical device manufacturer AngioDynamics. [More]
Study: Cognitive dysfunction in patients who undergo CABG surgery disappears within 8 weeks

Study: Cognitive dysfunction in patients who undergo CABG surgery disappears within 8 weeks

The cognitive dysfunction observed in patients who undergo coronary artery bypass grafting surgery usually disappears within 8 weeks following surgery, according to a study published in the April 2013 issue of The Annals of Thoracic Surgery. [More]
AACN selects seven Pennsylvania hospitals to participate in nurse leadership training program

AACN selects seven Pennsylvania hospitals to participate in nurse leadership training program

The American Association of Critical-Care Nurses selects seven Pennsylvania hospitals as the newest participants in its hospital-based nurse leadership and innovation training program. [More]

Patients at Michigan hospitals less likely to experience catheter-associated UTIs: Study

Patients at Michigan hospitals are less likely to experience a urinary tract infection caused by a catheter than at other hospitals in the country, according to a new study by the University of Michigan. [More]
Blocked bile ducts can be effectively treated with metal stents

Blocked bile ducts can be effectively treated with metal stents

A multi-center analysis, led by Weill Cornell Medical College and published in the Journal of Clinical Gastroenterology, shows the use of temporary "fully covered self-expanding metal stents" (FCSEMS) can effectively fix a painful and potentially life-threatening benign biliary stricture -- a severely blocked or narrowed bile duct. [More]
Cedars-Sinai surgeons perform more adult heart transplants in 2012, statistics show

Cedars-Sinai surgeons perform more adult heart transplants in 2012, statistics show

For the third year in a row, the Cedars-Sinai Heart Institute and Comprehensive Transplant Center performed more adult heart transplants than any other U.S. medical center, according to statistics compiled by the United Network for Organ Sharing, the nonprofit organization that manages the nation's transplant system. [More]
Importance of choosing correct catheter placement in hospitalized children

Importance of choosing correct catheter placement in hospitalized children

Location, location, location. A new Johns Hopkins Children's Center study shows the real-estate mantra also holds true when it comes to choosing correct catheter placement in children. [More]

Researchers find no overall recovery benefit to patients treated with clot-removal devices

When someone has a stroke, time equals brain. The longer a stroke is left untreated, the more brain tissue is lost. Since the only proven treatment - a clot-busting drug - works in less than half of patients, stroke physicians had high hopes for a mechanical device that could travel through the blocked blood vessel to retrieve or break up the clot, restoring blood flow to the brain. [More]
UCLA team uses brain aneurysm treatment technique to treat irregular heart rhythms

UCLA team uses brain aneurysm treatment technique to treat irregular heart rhythms

For the first time, a UCLA team has used a technique normally employed in treating brain aneurysms to treat severe, life-threatening irregular heart rhythms in two patients. [More]

Combination of stem cell therapy and physical therapy can reverse effects of spinal cord injury

Walking is the obvious goal for individuals who have a chronic spinal cord injury, but it is not the only one. Regaining sensation and continence control also are important goals that can positively impact an individual's quality of life. [More]
New procedure to treat pseudotumor cerebri

New procedure to treat pseudotumor cerebri

A team of interventional neuroradiologists and neurosurgeons at Johns Hopkins reports wide success with a new procedure to treat pseudotumor cerebri, a rare but potentially blinding condition marked by excessive pressure inside the skull, caused by a dangerous narrowing of a vein located at the base of the brain. [More]

Catheter-delivered aortic valve durable at three years

All-cause and cardiovascular mortality were similar for transaortic valve replacement compared to open-heart surgery in high-risk older patients at three years with no increased risk of stroke after 30 days, according to results from the PARTNER study presented today at the American College of Cardiology's 62nd Annual Scientific Session. [More]